Systematic review with meta‐analysis: the efficacy of levofloxacin triple therapy as the first‐ or second‐line treatments of Helicobacter pylori infection
Alimentary Pharmacology & Therapeutics2016Vol. 44(5), pp. 427–437
Citations Over TimeTop 10% of 2016 papers
Abstract
The efficacy of levofloxacin triple therapy has been lower than 80% in many countries and it is not recommended when the levofloxacin resistance is higher than 5-10%.
Related Papers
- → Two Different Concentrations of Topical Levofloxacin for the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Keratitis(2015)3 cited
- Pharmacokinetics of levofloxacin in patients with pneumonia(2006)
- Factor analysis of levofloxacin led phlebitis(2011)
- Study on the uptake of levofloxacin by gastric epithelial system cells(2014)
- Medical Efficiency and Safety Analysis on Levofloxacin Gel against M.TB In Vitro(2007)